The issue will feature guest editor Nate Apathy, Ph.D., from the University of Maryland School of Public Health in College ...

The design of the Enhancing Oncology Model (EOM) was a perfect fit for Minnesota Oncology.

Extranodal non-Hodgkin lymphoma (NHL) makes up over one-third of NHL cases, yet remains understudied and in need of deeper ...

Panelists discuss how switching therapies in patients with alopecia areata (AA) is often necessary when initial treatments ...

Chelsee Jensen, PharmD, BCPS, senior pharmacy specialist at Mayo Clinic, suggests that medical providers can reduce patient ...

According to a review of hospital-based cross-sectional studies, almost half the type 2 diabetes population is micronutrient ...

The latest semaglutide (Ozempic; Novo Nordisk) approval is set to tackle a major need for patients with both type 2 diabetes ...

First-line maintenance (1LM) niraparib significantly extends progression-free survival (rwPFS) and time to next treatment ...

According to the CDC, frequent consumption of sugary drinks is linked to adverse health outcomes that include obesity, type 2 ...

The pause has raised concerns among health officials and state leaders, as the vague wording leaves billions in Medicaid ...

Kirollos Hanna, PharmD, BCPS, BCOP, FACCC, director of pharmacy at Minnesota Oncology, discusses how the prospect of patient ...

The annual wellness visit is beneficial for patients, providers, and payers with an emphasis on preventive care for early ...